DOI 10.1038/s41598-026-47088-3
Nanoparticle-enriched mass spectrometry enables comprehensive plasma proteomics and reveals novel candidates for mild cognitive impairment.
Аннотация
UNLABELLED: Mild cognitive impairment (MCI) is a precursor to Alzheimer’s disease (AD), underscoring the need for reliable biomarkers for early identification. Here, we employed an automated nanoparticle-enrichment sample preparation platform combined with liquid chromatography–tandem mass spectrometry (LC–MS/MS) to facilitate comprehensive and unbiased detection of low-abundance proteins (LAPs). Through profiling of plasma proteomes from 42 individuals with MCI and 13 cognitively normal controls (NC), we identified 35 differentially expressed proteins (DEPs), of which four prioritized candidates were significantly correlated with Mini-Mental State Examination (MMSE) scores. Composite panels of candidate proteins showed potential to discriminate MCI, APOE4-carrier MCI, and amnestic MCI subtypes cases from NC, potentially providing insight into pathophysiological mechanisms underlying cognitive impairment. These findings highlight novel blood-based protein candidates uncovered by overcoming key limitations of conventional plasma proteomics, with potential to support MCI diagnosis.
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-47088-3.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.